Dexcom: Pay

Dexcom paid its 5 named executives $34.4M in total in FY2025 (Dec).

Pay$100 in the stock at the end of FY20 → $134
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Kevin R. SayerChairperson, President & Chief Executive Officer
FY2023 (Dec)
FY2022 (Dec)
FY2021 (Dec)
3 years
Jacob S. LeachEVP, Chief Operating Officer
FY2025 (Dec)
FY2023 (Dec)
FY2022 (Dec)
FY2021 (Dec)
4 years
Jereme M. SylvainEVP, Chief Financial Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
FY2021 (Dec)
5 years
Jon ColemanEVP, Chief Commercial Officer
FY2025 (Dec)
1 year
Michael J. BrownEVP, Chief Legal Officer
FY2025 (Dec)
FY2023 (Dec)
FY2022 (Dec)
3 years
Sadie M. SternEVP, Chief Human Resources Officer
FY2025 (Dec)
1 year

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 14 peers with pay on file was $19.6M. CEO pay of Dexcom for that year is not on file.

  1. 1Veeva Systems
  2. 2Workday
  3. 3Docusign
  4. 4Amgen
  5. 5Boston Scientific
  6. 6Intuitive Surgical
  7. 7Moderna
  8. 8Align Technology
  9. 9Insulet
  10. 10Edwards Lifesciences
  11. 11Zimmer Biomet Holdings
  12. 12Resmed
  13. 13Agilent Technologies
  14. 14Illumina
  15. 15DexcomNot disclosed
  16. 16BioMarin Pharmaceutical Inc.Not disclosed
  17. 17Exact Sciences CorporationNot disclosed
  18. 18Hologic, Inc.Not disclosed
  19. 19IDEXX Laboratories, Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.